FORT WORTH, Texas, June 30 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), has announced the signing of a commission based, sales agreement for its wound care product, CellerateRx(R), with EWA Government Systems, Inc. (EWA GSI). This agreement follows discussions and demonstrations, and validates that CellerateRx is destined to play a vital role in international wound management. CellerateRx patented collagen fragments (CRX) are a fraction of the size of native collagen molecules found in other products, and provide the benefits of collagen to the body immediately. The product provides unprecedented range of use, cost savings and patient friendliness.
"We believe that this agreement is a huge step for us, and that EWA GSI's capabilities in marketing our product represent a strong alliance with a major distributor that facilitates the needs of government entities," stated Scott Haire, CEO of Wound Management Technologies, Inc.
"While we are excited about the revenue opportunities, we are appreciative of EWA GSI's recognition that CellerateRx will play a key role in assisting physicians in wound management both domestically and now in the international markets as well," continued Haire.
The agreement grants to EWA GSI the right to market both the gel and powder forms of CellerateRx and will be compensated strictly on a commission basis for products sold.
About EWA Government Systems, Inc.:
EWA Government Systems, Inc. (EWA GSI) provides the highest quality products and services across a broad range of technology and engineering specialties to a variety of industries including national defense, the Federal Government, law enforcement, emergency response, healthcare, and entertainment. They also provide comprehensive analyses, engineering, and management services to the DoD community and to Federal and Civil agencies. EWA GSI also supports the Center for National Response.
EWA GSI is represented by the finest people who continually rise above expectations to achieve extraordinary results. At EWA GSI, they remain true in their commitment to customers both old and new, delivering innovative and enduring solutions for a competitive world.
To learn more about EWA Government Systems, Inc. please visit http://www.ewa-gsi.com
Wound Care Technologies, Inc. (OTC Bulletin Board: WNDM) with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at http://www.CellerateRX.com .
"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
Compensation Disclaimer: Capital Pros Network CPN has been compensated the equivalent of $60,000 from WNDM.OB. Certain oral statements made by management from time to time and certain statements contained in press releases and periodic reports issued by Capital Pros Network or WNDNM.OB (the "Company"), as well as those contained herein, that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934 and, because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.
|SOURCE Wound Management Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved